Programmed Death Ligand-1 (PD-L1) Expression in Endometrial Carcinoma: An Immunohistochemical Study and Correlation with Clinicopathological Parameters
Endometrial carcinoma (EC) is among the most prevalent gynecological malignancies worldwide, with increasing incidence linked to obesity and aging populations. Programmed death-ligand 1 (PD-L1) plays a crucial role in tumor immune evasion by interacting with PD-1, and its expression has been implicated in the aggressiv...